Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Flashwave® Diabetes

Where does Flashwave® help treat DIABETES related complications?

Diabetic Foot Syndrome (DFS)

Chronic wounds on patients with DFS

Diabetes related desensitizing of extremities

Diabetes related erectile dysfunction

With the unique Flashwave® technology even severely affected areas can be treated comfortably, it’s bespoke CCI® allowing easy access, a high degree of accuracy and short treatment time.

Flashwave® as Biocellular Transductive Wave Therapy activates cellular communication, leading to an increase in perfusion and arteriogenesis, biofilm disruption, a pro-inflammatory response, cytokine and chemokine effects, growth factor upregulation, angiogenesis and the subsequent regeneration of tissue such as skin, musculoskeletal and vascular structures.

Flashwave® technology is highly effective across a wide range of medical applications. The ability to communicate with different cells allows for treatment and management of vastly different diabetes-related medical
indications, as Biocellular Transductive Wave Therapy counteracts the typical complications caused by diabetes, such as reduced blood flow, neuropathy and vascular disease.

As little as three Flashwave® treatments may suffice to show significant improvement in the aforementioned diabetes-related complications, no matter how long the patient has been suffering from them before the treatment.